Medexus Pharmaceuticals Inc. (MEDXF) Financials

MEDXF Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 147.3 million 98.3 million
Dec. 31, 2025 155.0 million 102.8 million
Sept. 30, 2025 149.4 million 97.0 million
June 30, 2025 153.8 million 100.8 million

MEDXF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -11.2 million 165000
Dec. 31, 2025 7.8 million -6000
Sept. 30, 2025 3.3 million -122000
June 30, 2025 3.8 million 167000

MEDXF Net Income

No data available :(

MEDXF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 6.5 million 20.1 million -
Dec. 31, 2025 15.0 million 18.2 million -
Sept. 30, 2025 9.4 million 118000 -
June 30, 2025 9.3 million 159000 -

MEDXF Shares Outstanding

No data available :(

MEDXF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 15.0 million 2.2 million 9.4 million 1.8 million
Dec. 31, 2025 19000 859617 9.3 million 1.4 million
Sept. 30, 2025 7000 1.8 million 10.2 million 1.9 million
June 30, 2025 125000 2.4 million 10.5 million 2.3 million

MEDXF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 24.7 million 11.4 million
Dec. 31, 2025 25.3 million 11.7 million
Sept. 30, 2025 24.7 million 11.0 million
June 30, 2025 24.6 million 10.8 million

MEDXF

Price: $3.64

52 week price:
1.80
3.68

Earnings Per Share: -0.02 USD

P/E Ratio: -114.50

Exchange: OQX

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Market Capitalization: 114.3 million

Links: